Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
April 05, 2022
Tickers
NVS
Tags
Phase 3 Trial
Health Care
General
From
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Tickers
ACAD
ARGX
ATRA
BMY
Tags
NVS
FLDM
HTGC
From
Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
Tickers
ABBV
ALNY
AMGN
APTX
Tags
PFE
CHRS
Stocks to Buy
From
InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Monday, April 4
April 04, 2022
Tickers
AAPL
CRRFY
FRCOY
MMM
Tags
News
NVS
Top Stories
From
Benzinga
Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
April 04, 2022
Tickers
NVS
Tags
NVS
Briefs
News
From
Benzinga
3 CEOs to Invest In
April 01, 2022
Tickers
ANTM
AXSM
AZN
GH
Tags
Recent Press Releases
NVS
GSK
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
Benzinga
BHVN
LLY
From
Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
Tickers
ACMR
AMGN
BABA
BGNE
Tags
BMY
HCM
YUMC
From
InvestorPlace
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Tickers
ADMP
AFIB
AFMD
AGRX
Tags
OPGN
SPRO
IBB
From
Benzinga
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
March 27, 2022
Tickers
AZN
GRFS
GSK
JNJ
Tags
JNJ
NVAX
NVS
From
Motley Fool
Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
March 25, 2022
Tickers
NVS
Tags
Market News
Benzinga
NVS
From
Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
Tickers
INCY
NVO
NVS
Tags
Recent Press Releases
NVO
INCY
From
Motley Fool
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
Tickers
AMGN
CANF
NVS
Tags
Health Care
General
NVS
From
Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
March 24, 2022
Tickers
NVS
Tags
General
Health Care
News
From
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers
AHPA
APLS
ASND
ATHA
Tags
LLY
Penny Stocks
Benzinga
From
Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
March 22, 2022
Tickers
FUSN
LNTH
NVS
PNT
Tags
Small Cap
Biotech
Market News
From
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022
Tickers
ADMP
AGTC
ANAB
APTO
Tags
STAB
CTLT
APTO
From
Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
March 22, 2022
Tickers
BABA
BYDDY
CP
FB
Tags
PLD
CP
GS
From
Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
March 22, 2022
Tickers
NVS
Tags
Benzinga
Market News
Russia/Ukraine War
From
Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
Tickers
AAPL
AMC
AZN
BABA
Tags
GSK
JP:NIK
BE:UCB
From
MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
March 19, 2022
Tickers
NVS
PFE
VYGR
Tags
VYGR
PFE
Recent Press Releases
From
Motley Fool
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
Recent Press Releases
RHHBY
VIVO
From
Motley Fool
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study
March 14, 2022
Tickers
NVS
Tags
Trading Ideas
Benzinga
Market News
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
BIIB
Health Care
RHHBY
From
Benzinga
Why Another ADHD Stimulant? Cingulate Inc. Believes It's All About The Timing
March 14, 2022
Tickers
CING
JNJ
NVS
Tags
General
Biotech
NVS
From
Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now
March 14, 2022
Tickers
CRSP
LLY
NVS
VRTX
Tags
LLY
VRTX
XLV
From
Motley Fool
Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
March 11, 2022
Tickers
HCM
JNJ
NVS
Tags
NVS
JNJ
Market News
From
Benzinga
NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting
March 10, 2022
Tickers
NVS
Tags
breast cancer
Market News
Benzinga
From
Benzinga
7 Drug Stocks To Consider After the Viatris Plunge
March 10, 2022
Tickers
ABBV
BMY
GSK
JNJ
Tags
GSK
NVS
VTRS
From
InvestorPlace
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Tickers
ADMA
ANIK
AQST
AXDX
Tags
News
EVOK
STIM
From
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.